Marion Fournier
Marion Fournier is an expert in Oncology at Institut Bergonié (France). Marion Fournier has authored 91 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 288 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Public Health - Radiotherapy - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 91
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer. PMID 42613747 — aromatase, aromatase inhibitors, breast neoplasms, pain, arthralgia, neoplasms, breast | J Natl Cancer Inst | 2026 | 0 |
| Adenoid cystic carcinoma of the breast: a case series of 26 patients. PMID 42283891 — genes, myb, genes, carcinoma, adenoid cystic, breast neoplasms, neoplasms, breast, therapeutics, adenoids, prognosis | Breast Cancer Res Treat | 2026 | 0 |
| Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort. PMID 42265714 — breast neoplasms, lymphocytes, lymphopenia, neoplasms, breast, therapeutics | Breast Cancer Res | 2026 | 0 |
| Feasibility and safety of repeat breast-conserving surgery with intraoperative irradiation for local breast carcinoma recurrences: A phase 2 trial. PMID 42001960 — radiotherapy, mastectomy, estrogens, safety, breast neoplasms, fibrosis, receptors, estrogen, re-irradiation, breast, therapeutics | Radiother Oncol | 2026 | 0 |
| Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study. PMID 41120638 — breast neoplasms, neoplasms, cohort studies, breast, work, diagnosis, return to work, education | Br J Cancer | 2025 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map